Pyrilamine maleate
CAS No. 59-33-6
Pyrilamine maleate ( NSC 3604; Pyrilamine )
Catalog No. M15200 CAS No. 59-33-6
A histamine H1 antagonist. It has mild hypnotic properties and some local anesthetic action and is used for allergies (including skin eruptions) both parenterally and locally.
Purity : >98%(HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
50MG | 27 | In Stock |
|
100MG | 39 | In Stock |
|
200MG | 52 | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePyrilamine maleate
-
NoteResearch use only, not for human use.
-
Brief DescriptionA histamine H1 antagonist. It has mild hypnotic properties and some local anesthetic action and is used for allergies (including skin eruptions) both parenterally and locally.
-
DescriptionA histamine H1 antagonist. It has mild hypnotic properties and some local anesthetic action and is used for allergies (including skin eruptions) both parenterally and locally. It is a common ingredient of cold remedies.
-
SynonymsNSC 3604; Pyrilamine
-
PathwayGPCR/G Protein
-
TargetHistamine Receptor
-
RecptorH1 receptor
-
Research AreaOther Indications
-
Indication——
Chemical Information
-
CAS Number59-33-6
-
Formula Weight401.47
-
Molecular FormulaC21H27N3O5
-
Purity>98%(HPLC)
-
SolubilitySoluble in DMSO
-
SMILESCN(C)CCN(CC1=CC=C(C=C1)OC)C2=CC=CC=N2.C(=C\C(=O)O)\C(=O)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Moriyama K, et al. Inflamm Res. 2009 Dec;58(12):873-80.
molnova catalog
related products
-
Rupatadine Fumarate
Rupatadine is an inhibitor of PAFR and histamine (H1) receptor with Ki of 550 nM and 102 nM, respectively.
-
Ciproxifan maleate
Ciproxifan maleate(FUB-359 maleate) is a highly potent and selective histamin H3-receptor antagonist with IC50 of 9.2 nM, with low apparent affinity at other receptor subtypes.
-
Cetirizine dihydroch...
A second-generation antihistamine that acts as a selective H1 receptor antagonist.